Fund shareholders of Sarepta Therapeutics Inc
ISIN US8036071004 · United States · LEI 549300IKDPIED8J8IG21
- Fund shareholders
- 271
- Of which ETFs
- 71 200 other funds
- Value held
- 826.2M $ 1.2M € · 7.4M SEK
- Share of capital
- 36.9 % of 105.6M shares on Jul 31, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| BlackRock Tactical Opportunities Fund BlackRock Funds | 2,698 | 56.3K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Value Equity Index Fund GuideStone Funds | 2,584 | 56.2K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| AQR MS Fusion HV Fund AQR Funds | 2,556 | 55.6K $ | 0.10 % | 0.00 % | as of Mar 31, 2026 ↗ |
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 2,502 | 54.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| LVIP Dimensional U.S. Core Equity 1 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 2,493 | 54.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| AZL DFA U.S. Core Equity Fund Allianz Variable Insurance Products Trust | 2,441 | 53.1K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Intech S&P Small-Mid Cap Diversified Alpha ETF Tidal Trust III | 2,381 | 49.7K $ | 0.04 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Eventide Small Cap ETF Strategy Shares | 2,314 | 48.3K $ | 0.19 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Voya VACS Index Series MC Portfolio Voya VARIABLE PORTFOLIOS INC | 2,157 | 46.9K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 2,126 | 46.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PD Mid-Cap Index Portfolio PACIFIC SELECT FUND | 2,087 | 45.4K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| VOYA RUSSELLTM MID CAP GROWTH INDEX PORTFOLIO Voya VARIABLE PORTFOLIOS INC | 2,034 | 44.3K $ | 0.06 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Health Care Fund Rydex Series Funds | 1,992 | 43.3K $ | 0.23 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SIMT LARGE CAP INDEX FUND SEI INSTITUTIONAL MANAGED TRUST | 1,900 | 41.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| AZL Russell 1000 Growth Index Fund Allianz Variable Insurance Products Trust | 1,822 | 39.6K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Multimanager Aggressive Equity Portfolio EQ Advisors Trust | 1,700 | 37K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 1,543 | 33.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| LVIP Dimensional U.S. Core Equity 2 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 1,489 | 32.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 1,450 | 31.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| JNL/DFA U.S. Core Equity Fund JNL Series Trust | 1,432 | 31.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Growth Fund VALIC Co I | 1,346 | 22.6K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| SA Multi-Managed Mid Cap Growth Portfolio SEASONS SERIES TRUST | 1,281 | 27.9K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| EQ/Mid Cap Value Managed Volatility Portfolio EQ Advisors Trust | 1,281 | 27.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs MarketBeta(R) Russell 1000 Growth Equity ETF Goldman Sachs ETF Trust | 1,281 | 21.5K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| PROFUND VP SMALLCAP GROWTH ProFunds | 1,274 | 27.7K $ | 0.18 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Bridge Builder Large Cap Value Fund Bridge Builder Trust | 1,262 | 27.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Small Company Value Portfolio Wilshire Mutual Funds Inc | 1,200 | 26.1K $ | 0.12 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Ultra SmallCap600 ProShares Trust | 1,148 | 19.2K $ | 0.08 % | 0.00 % | as of Feb 28, 2026 ↗ |
| WisdomTree U.S. SmallCap Quality Growth Fund WisdomTree Trust | 1,103 | 24K $ | 0.25 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Flex Mid Cap Focused Index Fund Fidelity Salem Street Trust | 1,052 | 22K $ | 0.16 % | 0.00 % | as of Apr 30, 2026 ↗ |
| AQR MS Fusion Fund AQR Funds | 1,048 | 22.8K $ | 0.11 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Health Care Fund Rydex Variable Trust | 1,044 | 22.7K $ | 0.18 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP SMALLCAP VALUE ProFunds | 1,028 | 22.4K $ | 0.11 % | 0.00 % | as of Mar 31, 2026 ↗ |
| AQR CVX Fusion Fund AQR Funds | 1,018 | 22.2K $ | 0.08 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Wilmington Large-Cap Strategy Fund Wilmington Funds | 965 | 20.1K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| EQ/Large Cap Value Managed Volatility Portfolio EQ Advisors Trust | 932 | 20.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| GuideMark Small/Mid Cap Core Fund GPS Funds I | 922 | 20.1K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Disciplined U.S. Small Cap Equity Portfolio GLENMEDE FUND INC | 918 | 19.2K $ | 0.60 % | 0.00 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio MSCI Global Stock Market ETF SPDR INDEX SHARES FUNDS | 756 | 16.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| The Institutional U.S. Equity Portfolio HC Capital Trust | 676 | 14.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 569 | 12.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 549 | 9.2K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 500 | 10.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| EQ/Large Cap Value Index Portfolio EQ Advisors Trust | 497 | 10.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) 1500 Value Tilt ETF SPDR SERIES TRUST | 474 | 10.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Wilshire 5000 Index Fund Wilshire Mutual Funds Inc | 463 | 10.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Schwab U.S. Large-Cap Value Index Fund SCHWAB CAPITAL TRUST | 460 | 9.6K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Bridge Builder Small/Mid Cap Value Fund Bridge Builder Trust | 443 | 9.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| AMT Diversified Equity Fund ADVISER MANAGED TRUST | 441 | 9.2K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| WisdomTree BioRevolution Fund WisdomTree Trust | 427 | 9.3K $ | 0.41 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Innovator U.S. Small Cap Managed 10 Buffer ETF Innovator ETFs Trust | 402 | 8.4K $ | 0.11 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 385 | 8.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| LargeCap Growth Account I Principal Variable Contract Funds, Inc | 380 | 8.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP GROWTH PROFUND ProFunds | 346 | 7.2K $ | 0.16 % | 0.00 % | as of Apr 30, 2026 ↗ |
| SMALL-CAP VALUE PROFUND ProFunds | 280 | 5.8K $ | 0.10 % | 0.00 % | as of Apr 30, 2026 ↗ |
| LargeCap Value Fund III Principal Funds, Inc | 232 | 4.8K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| LVIP JPMorgan Select Mid Cap Value Managed Volatility Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 220 | 4.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| MidCap Value Fund I Principal Funds, Inc | 196 | 4.1K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Columbia Research Enhanced Value ETF Columbia ETF Trust I | 129 | 2.7K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| BlackRock Managed Volatility V.I. Fund BlackRock Variable Series Funds, Inc. | 112 | 2.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SA Multi-Managed Mid Cap Value Portfolio SEASONS SERIES TRUST | 112 | 2.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| E*TRADE No Fee Total Market Index Fund E Trade Trust | 110 | 2.3K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| New Covenant Growth Fund NEW COVENANT FUNDS | 87 | 1.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis Inflation Focused Equity ETF American Century ETF Trust | 75 | 1.3K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Avantis Responsible U.S. Equity ETF American Century ETF Trust | 48 | 804.5 $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Columbia Research Enhanced Mid Cap ETF Columbia ETF Trust I | 22 | 478.7 $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) 1500 Momentum Tilt ETF SPDR SERIES TRUST | 11 | 239.4 $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| LAGO ERIE, SICAV, S.A. GESALCALA, S.A., S.G.I.I.C. | 426.2K € | 1.14 % | as of Dec 31, 2025 ↗ | ||
| TRUVI VALUE FI GESIURIS ASSET MANAGEMENT, SGIIC, S.A. | 366.4K € | 3.42 % | as of Dec 31, 2025 ↗ | ||
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 366.3K € | 0.44 % | as of Dec 31, 2025 ↗ | ||
| DIRECTOR GROWTH, FI INVERSIS GESTIÓN, S.A., SGIIC | 12.9K € | 0.39 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| TRUVI VALUE FI GESIURIS ASSET MANAGEMENT, SGIIC, S.A. | 3.42 % | as of Dec 31, 2025 ↗ |
| First Trust NYSE Arca Biotechnology Index Fund First Trust Exchange-Traded Fund | 3.24 % | as of Mar 31, 2026 ↗ |
| iShares Neuroscience and Healthcare ETF iShares Trust | 2.21 % | as of Apr 30, 2026 ↗ |
| Virtus Biotech Etf ETFis Series Trust I | 1.55 % | as of Apr 30, 2026 ↗ |
| Global X Genomics & Biotechnology ETF GLOBAL X FUNDS | 1.31 % | as of Feb 28, 2026 ↗ |
| First Trust Health Care AlphaDEX Fund First Trust Exchange-Traded AlphaDEX Fund | 1.25 % | as of Apr 30, 2026 ↗ |
| LAGO ERIE, SICAV, S.A. GESALCALA, S.A., S.G.I.I.C. | 1.14 % | as of Dec 31, 2025 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 1.13 % | as of Feb 28, 2026 ↗ |
| Harbor Human Capital Factor US Small Cap ETF Harbor ETF Trust | 1.07 % | as of Apr 30, 2026 ↗ |
| Invesco S&P SmallCap Health Care ETF Invesco Exchange-Traded Fund Trust II | 1.05 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 266 | +6 | 38,989,939 | +8.7 % |
| 2026Q1 | 260 | -10 | 35,878,884 | +12.4 % |
| 2025Q4 | 270 | -52 | 31,920,416 | +19.9 % |
| 2025Q3 | 322 | -63 | 26,631,997 | -33.8 % |
| 2025Q2 | 385 | -63 | 40,206,470 | -1.6 % |
| 2025Q1 | 448 | -32 | 40,842,759 | +0.5 % |
| 2024Q4 | 480 | +6 | 40,621,064 | +6.0 % |
| 2024Q3 | 474 | +50 | 38,313,109 | +12.2 % |
| 2024Q2 | 424 | +26 | 34,146,551 | +3.0 % |
| 2024Q1 | 398 | -64 | 33,141,049 | -11.9 % |
| 2023Q4 | 462 | 37,623,800 |
Institutional managers
330 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 14,755,277 | 321.1M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 6,613,314 | 143.9M $ | as of Mar 31, 2026 |
| AQR CAPITAL MANAGEMENT LLC | 6,433,112 | 138.6M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 4,593,195 | 99.9M $ | as of Mar 31, 2026 |
| FIRST TRUST ADVISORS LP | 4,135,788 | 90M $ | as of Mar 31, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | 3,902,596 | 84.9M $ | as of Mar 31, 2026 |
| Erste Asset Management GmbH | 2,968,945 | 61.3M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 2,596,993 | 56.5M $ | as of Mar 31, 2026 |
| Aberdeen Group plc | 2,318,890 | 50.5M $ | as of Mar 31, 2026 |
| UBS Group AG | 2,232,459 | 48.6M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 2,145,926 | 46.7M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,988,796 | 43.3M $ | as of Mar 31, 2026 |
| FEDERATED HERMES, INC. | 1,786,021 | 38.9M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 1,665,078 | 36.2M $ | as of Mar 31, 2026 |
| CANADA PENSION PLAN INVESTMENT BOARD | 1,242,800 | 27M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 1,221,682 | 26.6M $ | as of Mar 31, 2026 |
| CITIGROUP INC | 1,147,648 | 25M $ | as of Mar 31, 2026 |
| T. Rowe Price Investment Management, Inc. | 1,133,308 | 24.7K $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 1,078,252 | 23.5M $ | as of Mar 31, 2026 |
| Connor, Clark & Lunn Investment Management Ltd. | 1,019,951 | 22.2M $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 897,532 | 19.5M $ | as of Mar 31, 2026 |
| Legal & General Group Plc | 866,743 | 18.9M $ | as of Mar 31, 2026 |
| Voleon Capital Management LP | 800,660 | 17.4M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 791,129 | 17.2M $ | as of Mar 31, 2026 |
| 683 Capital Management, LLC | 750,000 | 16.3M $ | as of Mar 31, 2026 |
Declared shareholders of Sarepta Therapeutics Inc
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Vanguard Portfolio Management | 6.43 % | 6,751,168 | as of Mar 31, 2026 · SCHEDULE 13G |
| Vanguard Capital Management | 5.11 % | 5,369,116 | as of Mar 31, 2026 · SCHEDULE 13G |
Funds holding the debt of Sarepta Therapeutics Inc
14 funds declare 16 bond lines of this company. The amount is the one the fund files. It is not a share of the debt, because no regulator publishes the amount outstanding in open access.
| Fund | Bond lines | Value | |
|---|---|---|---|
| Calamos Market Neutral Income Fund | 1 | 13.9M $ | as of Apr 30, 2026 |
| iShares Convertible Bond ETF | 1 | 12M $ | as of Apr 30, 2026 |
| State Street(R) SPDR(R) Bloomberg Convertible Securities ETF | 1 | 9.4M $ | as of Mar 31, 2026 |
| AQR Diversified Arbitrage Fund | 1 | 7.1M $ | as of Mar 31, 2026 |
| Fidelity Convertible Securities Fund | 2 | 3.5M $ | as of Feb 28, 2026 |
| Fidelity Strategic Dividend and Income Fund | 2 | 1.4M $ | as of Feb 28, 2026 |
| Greenspring Income Opportunities Fund | 1 | 1.1M $ | as of Mar 31, 2026 |
| Simplify Opportunistic Income ETF | 1 | 838.8K $ | as of Mar 31, 2026 |
| TETON Convertible Securities Fund | 1 | 167.8K $ | as of Mar 31, 2026 |
| JNL Multi-Manager Alternative Fund | 1 | 161K $ | as of Mar 31, 2026 |
| 1290 VT Convertible Securities Portfolio | 1 | 125.1K $ | as of Mar 31, 2026 |
| Harbor Ares Systematic Convertible Securities Fund | 1 | 86.2K $ | as of Apr 30, 2026 |
| Lazard Enhanced Opportunities Portfolio | 1 | 80.5K $ | as of Mar 31, 2026 |
| PACE Alternative Strategies Investments | 1 | 25.7K $ | as of Apr 30, 2026 |
Cite this page
Titelia. "Fund shareholders of Sarepta Therapeutics Inc". https://titelia.com/en/stocks/sarepta-therapeutics-inc-US8036071004